Total and low-density lipoprotein cholesterol responses to ezetimibe in clinical practice.

  • Nigel Capps
  • Published 2006 in International journal of clinical practice
Clinical trials have shown that ezetimibe significantly improves lipid profiles when used as monotherapy or in combination with a statin or fibrate. To assess its effect in clinical practice, a retrospective audit of changes in total cholesterol (TC) and low-density lipoprotein cholesterol (LDLC) was conducted in 180 hospital outpatients (mean age 57 years… (More)